carmofur has been researched along with aclarubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anai, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
Jinno, H; Ohtaguro, K; Ueda, K; Watanabe, H | 1 |
2 other study(ies) available for carmofur and aclarubicin
Article | Year |
---|---|
Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Naphthacenes; Rectal Neoplasms; Succinate Dehydrogenase | 1988 |
[Combination effects of CDDP, ACR and HCFU on progressive urothelial tumors].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Naphthacenes; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1985 |